Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAP2C pseudogene 1 (RAP2CP1) is annotated as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to genes but generally nonfunctional due to mutations, lack of transcription, or translation. RAP2CP1 does not encode a known protein and is not considered to participate in biological processes or therapeutic pathways. Querying RAP2CP1 as a target is incorrect because it is a pseudogene, not a functional biological molecule or drug target. There is no evidence for its coding potential, direct functional activity, drug interactions, or therapeutic relevance. For comparison, RAP2C (Ras-related protein Rap2c) is a functional small GTPase, but RAP2CP1 is not the same and should not be conflated with the functional protein-coding gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAP2C pseudogene 1 (RAP2CP1).